StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.66−0.21 (-7.32%)

Close on Nov 16, 2026Market cap $23.98MP/E –Yield –

Nasus Pharma total assets

Total assets on the balance sheet at the end of each period.

Nasus Pharma's total assets was $12.45M at Jun 30, 2026. For fiscal 2025 it was $5.00M, up 597.9% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.00M+597.9%
FY2024Dec 31, 2024$717.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$12.45M–
Q4 FY2025Dec 31, 2025$5.00M–
Q2 FY2025Jun 30, 2025$639.00K–
Q4 FY2024Dec 31, 2024$717.00K–

More Nasus Pharma figures

See a number that looks wrong?